Clinical trials
Phase 2 Parkinson Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 7 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| University Health Network, Toronto | 4 |
| University of British Columbia | 3 |
| Biogen | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Sanofi | 2 |
| UCB Biopharma SRL | 2 |
| ApoPharma | 1 |
| Avanir Pharmaceuticals | 1 |
| Bial R&D Investments, S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 39 |
| Dyskinesias | 8 |
| Movement Disorders | 7 |
| Parkinsonian Disorders | 6 |
| Central Nervous System Diseases | 3 |
| Neurodegenerative Diseases | 3 |
| Basal Ganglia Diseases | 2 |
| Brain Diseases | 2 |
| Lewy Body Disease | 2 |
| Nervous System Diseases | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.